Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 215

1.

Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer.

Karginova O, Siegel MB, Van Swearingen AE, Deal AM, Adamo B, Sambade MJ, Bazyar S, Nikolaishvili-Feinberg N, Bash R, O'Neal S, Sandison K, Parker JS, Santos C, Darr D, Zamboni W, Lee YZ, Miller CR, Anders CK.

Mol Cancer Ther. 2015 Mar 30. [Epub ahead of print]

PMID:
25824335
2.

Thoughts on "human-centered veterinary medicine".

Parker JS.

J Am Vet Med Assoc. 2014 Oct 15;245(8):883. doi: 10.2460/javma.245.8.883. No abstract available.

PMID:
25285926
3.

Virus-mediated compartmentalization of the host translational machinery.

Desmet EA, Anguish LJ, Parker JS.

MBio. 2014 Sep 16;5(5):e01463-14. doi: 10.1128/mBio.01463-14.

4.

An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer.

Gatza ML, Silva GO, Parker JS, Fan C, Perou CM.

Nat Genet. 2014 Oct;46(10):1051-9. doi: 10.1038/ng.3073. Epub 2014 Aug 24.

PMID:
25151356
5.

Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer.

Prat A, Carey LA, Adamo B, Vidal M, Tabernero J, Cortés J, Parker JS, Perou CM, Baselga J.

J Natl Cancer Inst. 2014 Aug 19;106(8). pii: dju152. doi: 10.1093/jnci/dju152. Print 2014 Aug.

6.

Predicting response and survival in chemotherapy-treated triple-negative breast cancer.

Prat A, Lluch A, Albanell J, Barry WT, Fan C, Chacón JI, Parker JS, Calvo L, Plazaola A, Arcusa A, Seguí-Palmer MA, Burgues O, Ribelles N, Rodriguez-Lescure A, Guerrero A, Ruiz-Borrego M, Munarriz B, López JA, Adamo B, Cheang MC, Li Y, Hu Z, Gulley ML, Vidal MJ, Pitcher BN, Liu MC, Citron ML, Ellis MJ, Mardis E, Vickery T, Hudis CA, Winer EP, Carey LA, Caballero R, Carrasco E, Martín M, Perou CM, Alba E.

Br J Cancer. 2014 Oct 14;111(8):1532-41. doi: 10.1038/bjc.2014.444. Epub 2014 Aug 7.

8.

Postmortem ultrastructural analysis of a cornea transplanted with Descemet membrane endothelial keratoplasty.

Livny E, Parker JS, van der Kaaij M, Haasdijk ED, van der Wees J, Bruinsma M, Melles GR.

Cornea. 2014 Aug;33(8):790-4. doi: 10.1097/ICO.0000000000000156.

PMID:
24977986
9.

Integrated RNA and DNA sequencing improves mutation detection in low purity tumors.

Wilkerson MD, Cabanski CR, Sun W, Hoadley KA, Walter V, Mose LE, Troester MA, Hammerman PS, Parker JS, Perou CM, Hayes DN.

Nucleic Acids Res. 2014 Jul;42(13):e107. doi: 10.1093/nar/gku489. Epub 2014 Jun 26.

10.

Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.

Iglesia MD, Vincent BG, Parker JS, Hoadley KA, Carey LA, Perou CM, Serody JS.

Clin Cancer Res. 2014 Jul 15;20(14):3818-29. doi: 10.1158/1078-0432.CCR-13-3368. Epub 2014 Jun 10.

PMID:
24916698
11.

ABRA: improved coding indel detection via assembly-based realignment.

Mose LE, Wilkerson MD, Hayes DN, Perou CM, Parker JS.

Bioinformatics. 2014 Oct;30(19):2813-5. doi: 10.1093/bioinformatics/btu376. Epub 2014 Jun 6.

12.

Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling.

Zhao W, He X, Hoadley KA, Parker JS, Hayes DN, Perou CM.

BMC Genomics. 2014 Jun 2;15:419. doi: 10.1186/1471-2164-15-419.

13.

More on personhood for chimps.

Parker JS.

J Am Vet Med Assoc. 2014 Apr 15;244(8):894-5. No abstract available.

PMID:
24818309
14.

Comprehensive analysis of gene expression in human retina and supporting tissues.

Li M, Jia C, Kazmierkiewicz KL, Bowman AS, Tian L, Liu Y, Gupta NA, Gudiseva HV, Yee SS, Kim M, Dentchev T, Kimble JA, Parker JS, Messinger JD, Hakonarson H, Curcio CA, Stambolian D.

Hum Mol Genet. 2014 Aug 1;23(15):4001-14. doi: 10.1093/hmg/ddu114. Epub 2014 Mar 14.

PMID:
24634144
15.

ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.

Brooks SA, Brannon AR, Parker JS, Fisher JC, Sen O, Kattan MW, Hakimi AA, Hsieh JJ, Choueiri TK, Tamboli P, Maranchie JK, Hinds P, Miller CR, Nielsen ME, Rathmell WK.

Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035. Epub 2014 Feb 25.

PMID:
24613583
16.

People are people.

Parker JS.

J Am Vet Med Assoc. 2014 Mar 15;244(6):646. doi: 10.2460/javma.244.6.646. No abstract available.

PMID:
24568102
17.

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology.

Damrauer JS, Hoadley KA, Chism DD, Fan C, Tiganelli CJ, Wobker SE, Yeh JJ, Milowsky MI, Iyer G, Parker JS, Kim WY.

Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3110-5. doi: 10.1073/pnas.1318376111. Epub 2014 Feb 11.

18.

Equality of opportunity in veterinary medicine.

Parker JS.

J Am Vet Med Assoc. 2013 Dec 15;243(12):1677-8. No abstract available.

PMID:
24443763
19.

Prenatal arsenic exposure and the epigenome: altered microRNAs associated with innate and adaptive immune signaling in newborn cord blood.

Rager JE, Bailey KA, Smeester L, Miller SK, Parker JS, Laine JE, Drobná Z, Currier J, Douillet C, Olshan AF, Rubio-Andrade M, Stýblo M, García-Vargas G, Fry RC.

Environ Mol Mutagen. 2014 Apr;55(3):196-208. doi: 10.1002/em.21842. Epub 2013 Dec 10.

20.

Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.

Prat A, Karginova O, Parker JS, Fan C, He X, Bixby L, Harrell JC, Roman E, Adamo B, Troester M, Perou CM.

Breast Cancer Res Treat. 2013 Nov;142(2):237-55. doi: 10.1007/s10549-013-2743-3. Epub 2013 Oct 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk